BK vs GBIO · P/E 17, $94.14B cap vs rev $19.9M
The Bank of New York Mellon Corporation (BK) versus Generation Bio Co (GBIO) — a side-by-side from cached financials, not a winner call.
The Bank of New York Mellon Corporation (BK) is a banks - diversified company listed on US.
Generation Bio Co (GBIO) is a biotechnology company listed on US.
BK does not have a complete income-statement cache yet.
Latest reported GBIO revenue for 2024-12-31 was $19.9M. Net income was -$131.7M. Revenue was up 236.9% from 2023-12-31 to 2024-12-31. GBIO currently screens at market cap $25.4M.
BK currently screens at market cap $94.14B and trailing P/E 17.0. GBIO currently screens at market cap $25.4M.
Not investment advice. Open the BK and GBIO stock pages for the full models.
Not investment advice.